A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Abb Vie Inc. stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 738,532 shares of ABBV stock, worth $144 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
738,532
Previous 1,041,447 29.09%
Holding current value
$144 Million
Previous $190 Million 33.21%
% of portfolio
0.33%
Previous 0.5%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

SELL
$154.79 - $180.76 $46.9 Million - $54.8 Million
-302,915 Reduced 29.09%
738,532 $127 Million
Q1 2024

May 08, 2024

BUY
$159.82 - $182.1 $66 Million - $75.2 Million
412,920 Added 65.7%
1,041,447 $190 Million
Q4 2023

Feb 09, 2024

BUY
$137.6 - $154.97 $5.73 Million - $6.45 Million
41,615 Added 7.09%
628,527 $97.4 Million
Q3 2023

Nov 13, 2023

SELL
$133.59 - $154.65 $9.36 Million - $10.8 Million
-70,035 Reduced 10.66%
586,912 $87.5 Million
Q2 2023

Aug 08, 2023

BUY
$132.51 - $164.9 $31.7 Million - $39.5 Million
239,238 Added 57.27%
656,947 $88.5 Million
Q1 2023

May 08, 2023

SELL
$144.61 - $166.54 $21.2 Million - $24.4 Million
-146,763 Reduced 26.0%
417,709 $66.6 Million
Q4 2022

Feb 09, 2023

BUY
$138.31 - $165.87 $10.5 Million - $12.6 Million
75,897 Added 15.53%
564,472 $91.2 Million
Q3 2022

Nov 10, 2022

SELL
$134.21 - $153.93 $16.7 Million - $19.2 Million
-124,549 Reduced 20.31%
488,575 $65.6 Million
Q2 2022

Aug 04, 2022

BUY
$137.62 - $174.96 $19.8 Million - $25.1 Million
143,624 Added 30.59%
613,124 $93.9 Million
Q1 2022

May 12, 2022

BUY
$131.98 - $163.75 $6.74 Million - $8.36 Million
51,067 Added 12.2%
469,500 $76.1 Million
Q4 2021

Feb 09, 2022

SELL
$107.43 - $135.93 $18.5 Million - $23.4 Million
-172,322 Reduced 29.17%
418,433 $56.7 Million
Q3 2021

Nov 08, 2021

BUY
$106.4 - $120.78 $24.7 Million - $28 Million
231,950 Added 64.65%
590,755 $63.7 Million
Q2 2021

Aug 05, 2021

SELL
$105.21 - $117.21 $1.51 Million - $1.68 Million
-14,350 Reduced 3.85%
358,805 $40.4 Million
Q1 2021

May 05, 2021

BUY
$102.3 - $112.62 $918,551 - $1.01 Million
8,979 Added 2.47%
373,155 $40.4 Million
Q4 2020

Feb 12, 2021

BUY
$80.49 - $108.67 $6.15 Million - $8.31 Million
76,465 Added 26.58%
364,176 $39 Million
Q3 2020

Nov 09, 2020

SELL
$85.91 - $100.83 $9.47 Million - $11.1 Million
-110,223 Reduced 27.7%
287,711 $25.2 Million
Q2 2020

Aug 04, 2020

BUY
$73.37 - $98.18 $2.75 Million - $3.68 Million
37,472 Added 10.4%
397,934 $39.1 Million
Q1 2020

May 12, 2020

SELL
$64.5 - $97.79 $3.25 Million - $4.93 Million
-50,378 Reduced 12.26%
360,462 $27.5 Million
Q4 2019

Feb 11, 2020

BUY
$72.13 - $90.25 $572,567 - $716,404
7,938 Added 1.97%
410,840 $36.4 Million
Q3 2019

Nov 12, 2019

SELL
$62.98 - $75.72 $614,999 - $739,405
-9,765 Reduced 2.37%
402,902 $30.5 Million
Q2 2019

Aug 02, 2019

BUY
$65.7 - $83.98 $6.01 Million - $7.69 Million
91,541 Added 28.51%
412,667 $30 Million
Q1 2019

Apr 26, 2019

BUY
$77.14 - $90.79 $3.13 Million - $3.68 Million
40,565 Added 14.46%
321,126 $25.9 Million
Q4 2018

Feb 13, 2019

BUY
$77.85 - $96.01 $417,587 - $514,997
5,364 Added 1.95%
280,561 $25.6 Million
Q3 2018

Nov 13, 2018

BUY
$88.91 - $98.84 $1.03 Million - $1.15 Million
11,620 Added 4.41%
275,197 $26 Million
Q2 2018

Aug 01, 2018

BUY
$89.78 - $106.23 $5.98 Million - $7.08 Million
66,625 Added 33.83%
263,577 $24.4 Million
Q1 2018

May 07, 2018

BUY
$92.01 - $123.21 $3.05 Million - $4.08 Million
33,147 Added 20.24%
196,952 $18.6 Million
Q4 2017

Feb 01, 2018

BUY
$89.56 - $98.21 $2.9 Million - $3.18 Million
32,343 Added 24.6%
163,805 $15.8 Million
Q3 2017

Nov 02, 2017

BUY
$69.85 - $89.22 $9.18 Million - $11.7 Million
131,462
131,462 $11.7 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $344B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Bnp Paribas Asset Management Holding S.A. Portfolio

Follow Bnp Paribas Asset Management Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bnp Paribas Asset Management Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Bnp Paribas Asset Management Holding S.A. with notifications on news.